Tracers / [18F]F-A-85380

[18F]F-A-85380

Also written as [18F]F-A-85380; [F-18]F-A-85380
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
Syntheses indexed
1

What it is

Compound class
radiolabelled nicotinic acetylcholine receptor ligand (fluoropyridine derivative)
Target / mechanism
α4β2 nicotinic acetylcholine receptors (nAChRs) PMID 31168797
Clinical application
Patients with Alzheimer's disease and mild cognitive impairment PMID 18228017
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
more than 99%t-butyloxycarbonyl (BOC)-protected intermediate17448665
2007 Appl Radiat Isot
a commercially available TRACERlab FXF-N synthesis module

Need this precursor?We can point you to suppliers for [18F]F-A-85380, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]F-A-85380.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18. | Stage 28: added indication(s) psy-addiction from consolidated missing-rubric review.